A carregar...
Advances in Anti-GD2 Immunotherapy for Treatment of High-Risk Neuroblastoma
Neuroblastoma (NBL) is the most common extracranial solid tumor in pediatrics, yet overall survival is poor for high-risk cases. Immunotherapy regimens using a tumor-selective anti-disialoganglioside (anti-GD2) monoclonal antibody (mAb) have been studied for several decades now, but have only recent...
Na minha lista:
| Publicado no: | J Pediatr Hematol Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430125/ https://ncbi.nlm.nih.gov/pubmed/30897608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000001369 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|